Application of machine learning models to identify serological predictors of COVID-19 severity and outcomes.

COVID-19 death COVID-19 hospitalization IgG isotypes automated intelligence neutralizing antibody non-neutralizing antibody random forest model

Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
13 Nov 2023
Historique:
pubmed: 28 11 2023
medline: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Critically ill people with COVID-19 have greater antibody titers than those with mild to moderate illness, but their association with recovery or death from COVID-19 has not been characterized. In 178 COVID-19 patients, 73 non-hospitalized and 105 hospitalized patients, mucosal swabs and plasma samples were collected at hospital enrollment and up to 3 months post-enrollment (MPE) to measure virus RNA, cytokines/chemokines, binding antibodies, ACE2 binding inhibition, and Fc effector antibody responses against SARS-CoV-2. The association of demographic variables and >20 serological antibody measures with intubation or death due to COVID-19 was determined using machine learning algorithms. Predictive models revealed that IgG binding and ACE2 binding inhibition responses at 1 MPE were positively and C1q complement activity at enrollment was negatively associated with an increased probability of intubation or death from COVID-19 within 3 MPE. Serological antibody measures were more predictive than demographic variables of intubation or death among COVID-19 patients.

Identifiants

pubmed: 38014049
doi: 10.21203/rs.3.rs-3463155/v1
pmc: PMC10680931
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : U54 CA260492
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare no conflicts of interest.

Références

Sci Adv. 2022 Dec 23;8(51):eade5085
pubmed: 36563151
Cell. 2021 Jan 21;184(2):476-488.e11
pubmed: 33412089
mBio. 2021 Apr 20;12(2):
pubmed: 33879594
Cell. 2022 Feb 3;185(3):493-512.e25
pubmed: 35032429
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):25018-25025
pubmed: 32943538
Intervirology. 2020 Dec 9;:1-12
pubmed: 33296901
Front Artif Intell. 2021 Aug 13;4:579931
pubmed: 34514377
Sci Adv. 2021 Mar 5;7(10):
pubmed: 33674317
Clin Infect Dis. 2022 Jan 29;74(2):254-262
pubmed: 34013339
Eur J Intern Med. 2022 Apr;98:77-82
pubmed: 35177308
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Sci Rep. 2021 Feb 25;11(1):4673
pubmed: 33633145
JCI Insight. 2022 May 9;7(9):
pubmed: 35349483
Nat Rev Immunol. 2023 Jun;23(6):381-396
pubmed: 36536068
EBioMedicine. 2021 Sep;71:103546
pubmed: 34419924
Open Forum Infect Dis. 2020 Dec 30;8(2):ofaa648
pubmed: 33604399
mSphere. 2023 Feb 21;8(1):e0052222
pubmed: 36656002
Virol J. 2022 May 26;19(1):92
pubmed: 35619180
Cell Rep. 2021 Mar 16;34(11):108863
pubmed: 33691089
J Immunol Methods. 2023 Mar;514:113440
pubmed: 36773929
J Infect Dis. 2021 Aug 16;224(4):606-615
pubmed: 34398245
Open Forum Infect Dis. 2021 Aug 31;8(9):ofab448
pubmed: 34584899
J Immunol. 2019 Aug 1;203(3):749-759
pubmed: 31201239
Sci Immunol. 2020 Dec 7;5(54):
pubmed: 33288645
Future Virol. 2021 Sep;:
pubmed: 34567235
Clin Infect Dis. 2023 May 3;76(9):1539-1549
pubmed: 36528815
Sci Transl Med. 2022 Mar 9;14(635):eabm7853
pubmed: 35040666
Open Forum Infect Dis. 2021 Apr 16;8(6):ofab195
pubmed: 34095338
Science. 2022 Jan 07;375(6576):43-50
pubmed: 34812653
Viruses. 2023 Apr 20;15(4):
pubmed: 37112998
Front Cell Infect Microbiol. 2022 Apr 19;12:838749
pubmed: 35521216
Clin Infect Dis. 2020 Dec 17;71(10):2688-2694
pubmed: 32497196
Virol J. 2023 May 3;20(1):85
pubmed: 37138352
Open Forum Infect Dis. 2022 Dec 15;10(1):ofac677
pubmed: 36655185
J Clin Invest. 2020 Nov 2;130(11):6141-6150
pubmed: 32764200
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33067270
Viruses. 2022 May 18;14(5):
pubmed: 35632830
mSphere. 2022 Aug 31;7(4):e0019322
pubmed: 35703544
Lancet Microbe. 2022 Jan;3(1):e52-e61
pubmed: 34806056
J Med Internet Res. 2021 Apr 7;23(4):e23948
pubmed: 33714935
Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S61-S71
pubmed: 35607747

Auteurs

Sabra Klein (S)

Johns Hopkins Bloomberg School of Public Health.

Santosh Dhakal (S)

Johns Hopkins Bloomberg School of Public Health.

Anna Yin (A)

Johns Hopkins Bloomberg School of Public Health.

Zoe Demko (Z)

Johns Hopkins School of Medicine.

Nora Pisanic (N)

Johns Hopkins Bloomberg School of Public Health.

Trevor Johnston (T)

Johns Hopkins Bloomberg School of Public Health.

Maria Trejo-Zambrano (M)

Johns Hopkins School of Medicine.

Kate Kruczynski (K)

Johns Hopkins Bloomberg School of Public Health.

John Lee (J)

Johns Hopkins Bloomberg School of Public Health.

Justin Hardick (J)

The Johns Hopkins University.

Patrick Shea (P)

Johns Hopkins Bloomberg School of Public Health.

Janna Shapiro (J)

Johns Hopkins Bloomberg School of Public Health.

Han-Sol Park (HS)

Johns Hopkins Bloomberg School of Public Health.

Maclaine Parish (M)

Johns Hopkins Bloomberg School of Public Health.

Christopher Caputo (C)

Johns Hopkins Bloomberg School of Public Health, Baltimore.

Abhinaya Ganesan (A)

Johns Hopkins Bloomberg School of Public Health.

Sarika Mullapudi (S)

Johns Hopkins School of Medicine.

Stephen Gould (S)

Johns Hopkins University School of Medicine.

Michael Betenbaugh (M)

Johns Hopkins University.

Andrew Pekosz (A)

Johns Hopkins Bloomberg School of Public Health.

Annukka Antar (A)

Johns Hopkins School of Medicine.

Yukari Manabe (Y)

Division of Infectious Diseases, Department of Medicine, The Johns Hopkins School of Medicine.

Scott Zeger (S)

Johns Hopkins University.

Classifications MeSH